SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-013253
Filing Date
2017-11-14
Accepted
2017-11-14 17:03:21
Documents
93
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1484771
2 ex31-1.htm EX-31.1 17996
3 ex31-2.htm EX-31.2 17885
4 ex32-1.htm EX-32.1 7133
5 ex32-2.htm EX-32.2 7231
  Complete submission text file 0001493152-17-013253.txt   6253812

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20170930.xml EX-101.INS 1087786
7 XBRL SCHEMA FILE aker-20170930.xsd EX-101.SCH 74518
8 XBRL CALCULATION FILE aker-20170930_cal.xml EX-101.CAL 72877
9 XBRL DEFINITION FILE aker-20170930_def.xml EX-101.DEF 262986
10 XBRL LABEL FILE aker-20170930_lab.xml EX-101.LAB 460652
11 XBRL PRESENTATION FILE aker-20170930_pre.xml EX-101.PRE 383679
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 171202688
SIC: 2835 In Vitro & In Vivo Diagnostic Substances